Literature DB >> 23457024

A note on the expected biases in conventional iterative health state valuation protocols.

Laura Ternent1, Aki Tsuchiya2.   

Abstract

BACKGROUND: Typical health state valuation exercises use tradeoff methods, such as the time tradeoff or the standard gamble, involving a series of iterated questions so that a value for each health state by each individual respondent is elicited. This iterative process is a source of potential biases, but this has not received much attention in the health state valuation literature. The issue has been researched widely in the contingent valuation (CV) literature, which elicits the monetary value of hypothetical outcomes.
METHODS: The lessons learned in the CV literature are revisited in the context of the design and administration of health state valuations. The article introduces the main known biases in the CV literature and then examines how each might affect conventional iterative health state valuations.
RESULTS: Of the 8 main types of biases, starting point bias, range bias, and incentive incompatibility bias are found to be potentially relevant. Furthermore, the magnitude and direction of the bases are unlikely to be uniform and depend on the range of the value (e.g., between 0 and 0.5). Limitation. This is an overview article, and the conclusions drawn need to be tested empirically.
CONCLUSIONS: Health state valuation studies, like CV studies, are susceptible to a number of possible biases that affect the resulting values. Their magnitude and direction are unlikely to be uniform, and thus empirical studies are needed to diagnose the problem and, if necessary, to address it.

Keywords:  bias; contingent valuation; time tradeoff

Mesh:

Year:  2013        PMID: 23457024     DOI: 10.1177/0272989X12475093

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

1.  Challenges in measuring the societal value of orphan drugs: insights from a canadian stated preference survey.

Authors:  Nick Dragojlovic; Shirin Rizzardo; Nick Bansback; Craig Mitton; Carlo A Marra; Larry D Lynd
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

2.  Applicability of patient utilities as measures of overall quality of life in rheumatoid arthritis clinical trials.

Authors:  Michael M Ward; Lori C Guthrie
Journal:  Rheumatology (Oxford)       Date:  2016-10-27       Impact factor: 7.580

3.  Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues.

Authors:  Nick Bansback; Arne Risa Hole; Brendan Mulhern; Aki Tsuchiya
Journal:  Soc Sci Med       Date:  2014-05-20       Impact factor: 4.634

4.  Influenced from the start: anchoring bias in time trade-off valuations.

Authors:  Liv Ariane Augestad; Knut Stavem; Ivar Sønbø Kristiansen; Carl Haakon Samuelsen; Kim Rand-Hendriksen
Journal:  Qual Life Res       Date:  2016-03-26       Impact factor: 4.147

5.  New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year.

Authors:  Arthur E Attema; Marieke Krol; Job van Exel; Werner B F Brouwer
Journal:  Eur J Health Econ       Date:  2017-03-08

6.  An exploration of the non-iterative time trade-off method to value health states.

Authors:  Yan Feng; Arne Risa Hole; Milad Karimi; Aki Tsuchiya; Ben van Hout
Journal:  Health Econ       Date:  2018-05-17       Impact factor: 3.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.